Medical Consultants Intl. , Ltd.: FDA filings under this applicant name
FDA lists 6 510(k) clearances under the applicant name “Medical Consultants Intl. , Ltd.” (first 1990, latest 1991), across 4 product codes in 2 review panels. Median 510(k) review time under this name: 197 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| GZJ | Stimulator, Nerve, Transcutaneous, For Pain Relief | 2 | 2 |
| QJQ | Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety | 2 | 2 |
| GZL | Electrode, Depth | 1 | 1 |
| LWM | Device, Electrical Dental Anesthesia | 1 | 1 |
Review panels
Most recent Medical Consultants Intl. , Ltd. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K904264 | MODEL SW-103 SOLITANS STIMULATOR | GZJ | 1991-05-09 | 233 |
| K900731 | MEDI LISS DENTAL ANALGESIA DEVICE (SBL601) | LWM | 1990-12-17 | 305 |
| K903654 | LISS CRANIAL STIMULATOR MODEL SBL202-B | QJQ | 1990-10-04 | 90 |
| K902976 | MEDI MODEL SBL502-B (LISS BODY STIMULATOR) ZERO DC | GZL | 1990-09-07 | 63 |
| K894515 | LISS CRANIAL STIMULATOR MODEL SBL201-M | QJQ | 1990-05-03 | 288 |
| K896226 | LISS BODY STIMULATOR MODEL SBL501-M | GZJ | 1990-04-10 | 161 |
Recalls
openFDA lists no recalls under a recalling firm named Medical Consultants Intl. , Ltd..
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Medical Analysis Systems, Inc. (107 510(k)s)
- Medical Components, Inc. (63 510(k)s)
- Medical Advances, Inc. (57 510(k)s)
- Medical Diagnostic Technologies, Inc. (57 510(k)s)
- Medical Devices, Inc. (49 510(k)s)
- Medical Device Technologies, Inc. (46 510(k)s)
- Medical Specialties, Inc. (40 510(k)s)
- Medical Device Inspection Co., Inc. (30 510(k)s)
- Medical Engineering Corp. (28 510(k)s)
- Medical Data Electronics (27 510(k)s)
- Medical Graphics Corp. (25 510(k)s)
- Medical Innovations Corp. (24 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Medical Consultants Intl. , Ltd.?
FDA lists 6 510(k) clearances under the applicant name “Medical Consultants Intl. , Ltd.” (first 1990, latest 1991), across 4 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Medical Consultants Intl. , Ltd.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Medical Consultants Intl. , Ltd. is 197 days.
Which FDA product codes appear under Medical Consultants Intl. , Ltd.?
The most frequent FDA product codes under this applicant name are GZJ (Stimulator, Nerve, Transcutaneous, For Pain Relief, 2); QJQ (Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety, 2); GZL (Electrode, Depth, 1).
Next steps
- See all 6 Medical Consultants Intl. , Ltd. clearances with predicates and recalls
- Run predicate analysis for product code GZJ, Medical Consultants Intl. , Ltd.'s most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.